Skip to main content

Industries

IASO Bio's In Vivo CAR-T IASO206 Hits 90% Response Rate in Myeloma Trial

Shanghai – September 26, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.

Guangzhou Building Decoration Fair Sees Overseas Visitors Jump 33.4%

Image
Guangzhou Building Decoration Fair Sees Overseas Visitors Jump 33.4%

Guangzhou – – September 28, 2026 -- Overseas attendance at the 2026 China (Guangzhou) International Building Decoration Fair reached 11,473 visitors, up 33.4% year on year, with participants drawn from 147 countries and regions despite broader market pressures on the sector.

Exhibitor numbers grow as fair concludes at Canton Fair Complex

The 2026 edition wrapped at the Canton Fair Complex with exhibitor growth reported even as the home furnishing and building decoration industry navigates a shift away from a property-driven growth model toward renovation and upgrading. Chen Penghan, Sales Head of CBD Fair, said new opportunities lie in renovation, quality upgrades, intelligent innovation and broader channel development, pointing to early-stage brand globalization, supply-procurement mismatches and incomplete service chains as ongoing challenges.

CPKC Unit Prices C$1.8 Billion Four-Tranche Bond Offering

Image
CPKC Unit Prices C$1.8 Billion Four-Tranche Bond Offering

Calgary, AB – September 28, 2026 -- Canadian Pacific Railway Company (CPRC), the wholly owned subsidiary of Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP), is issuing C$1.8 billion in notes across four tranches, guaranteed by parent CPKC.

CPRC structures debt sale across four maturities from 2030 to 2056

The offering comprises C$500 million of 4.20% Notes due 2030, C$550 million of 4.60% Notes due 2033, C$300 million of 4.90% Notes due 2037 and C$450 million of 5.40% Notes due 2056. The staggered maturity profile spans 4 to 30 years, giving CPKC a blended long-term debt structure.

Net proceeds target refinancing of existing CPRC debt

CPKC stated the funds will be used primarily for refinancing outstanding indebtedness and for general corporate purposes. Until deployed, unused proceeds may be parked in short-term investment-grade securities, money market funds or bank deposits.

Sharpa Launches D01 Robot, W02 Hand, AE01 Glove at IROS 2026

Image
Sharpa Launches D01 Robot, W02 Hand, AE01 Glove at IROS 2026

Pittsburgh – September 28, 2026 -- Sharpa unveiled three flagship dexterous-manipulation products at IEEE/RSJ IROS 2026: the D01 integrated robot, the W02 tactile dexterous hand and the AE01 haptic exoskeleton data glove, expanding its hardware portfolio for human-environment robotics.

D01 integrates arms, hands and full-body electronic skin for tactile manipulation

D01 combines Sharpa Wave dexterous hands with seven-degree-of-freedom arms and whole-body electronic skin. The robot achieves an approximately 1:1 arm payload-to-weight ratio, a maximum end-effector speed exceeding 10.5 meters per second, communication frequency of 1,000 Hz and end-effector repeatability of 0.2 millimeters. Its electronic skin operates at a 100 Hz tactile sampling rate with 0.2 newton force resolution, extending contact sensing across the robot's body.

AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Image
AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Syracuse – – September 28, 2026 -- Fuse Oncology and Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Partners, a General Atlantic company, have launched a proof of concept for FuseRx, a clinical workflow platform for radiation oncology, at AMP's Center of Advanced Radiation Excellence in Syracuse.

Prostate cancer volume drives the test case

The American Cancer Society projects about 333,800 new U.S. prostate cancer cases in 2026, making it the most common cancer in American men after skin cancer. Roughly a third of men with localized disease receive radiation as primary treatment, a pathway that typically starts with a urologist diagnosis before crossing into separate oncology systems.

Responsible Fintech Institute Names Four Executive Fellows, Elevates Loh to Co-Founder

Image
Responsible Fintech Institute Names Four Executive Fellows, Elevates Loh to Co-Founder

Singapore – – September 28, 2026 -- The Responsible Fintech Institute (RFI) has appointed Professor Lawrence Loh, Associate Professor Eugene K.B. Tan, Professor Louis Chen and Ms Farah Jaafar as Executive Fellows, while elevating Distinguished Professor Patrick H. M. Loh to Co-Founder.

RFI expands leadership bench as digital finance regulation intensifies

The nonprofit, based in Singapore, said the appointments deepen its expertise in law, governance, digital policy and cross-border capital markets as regulators and institutions push to ground digital asset, AI and cross-border payment innovation in legal and ethical frameworks.

FDA Weighs Easing Tobacco Product Review Amid 7,500 Illegal Items

Image
FDA Weighs Easing Tobacco Product Review Amid 7,500 Illegal Items

Washington – September 28, 2026 -- The U.S. Food and Drug Administration announced plans to evaluate changes to its application framework for new tobacco products, including e-cigarettes and nicotine pouches, aiming to simplify the pathway for these products to reach the market.

Truth Initiative warns weakened review could undermine public health protections

Kathy Crosby, CEO and President of Truth Initiative, said any changes that reduce the scientific evidence required or diminish the review process would compromise the FDA's regulatory role. The law currently requires the agency to assess a product's components, ingredients, toxicological profile and health impact, alongside risks and benefits to the broader population, including youth and non-users.

Ascletis' Oral ASC50 Cuts Psoriasis Severity 48.9% in Phase I Trial

Image
Ascletis' Oral ASC50 Cuts Psoriasis Severity 48.9% in Phase I Trial

Hong Kong – – September 28, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) reported a 48.9% placebo-adjusted reduction in psoriasis area and severity index (PASI) scores from a 28-day U.S. proof-of-concept trial of ASC50, an oral small molecule IL-17A inhibitor positioned as a needle-free alternative to injectable antibody therapies for plaque psoriasis.

Once-daily 200 mg dosing matched published efficacy benchmarks for injectable IL-17A antibody secukinumab

The randomized, double-blind, placebo-controlled Phase I study (NCT07024602) enrolled mild-to-moderate plaque psoriasis patients who received once-daily 200 mg oral ASC50 for 28 days. Ascletis said the PASI reduction was comparable to published secukinumab data, though the comparison was not conducted head-to-head.

UMG Becomes First German University Hospital to Deploy MDClone ADAMS

Image
UMG Becomes First German University Hospital to Deploy MDClone ADAMS

Göttingen, Germany – September 28, 2026 -- University Medical Center Göttingen (UMG) has become the first hospital in Germany and the European Union to deploy MDClone's ADAMS platform, layering advanced data utilization tools onto its existing UMG-MeDIC data integration center.

UMG becomes first EU adopter of internationally deployed ADAMS model

ADAMS is already operational at institutions including UChicago Medicine, Manchester University NHS Foundation Trust, and Sheba Medical Center. UMG's rollout marks the model's first entry into a German or EU university hospital, building directly on infrastructure established under Germany's national Medical Informatics Initiative (MII).

askelie Launches askVERA AI Tool to Simplify Complex Documents

Image
askelie Launches askVERA AI Tool to Simplify Complex Documents

London – September 28, 2026 -- UK-based AI platform company askelie has launched askVERA, an AI-powered service that converts complex documents and communications into Plain English and Easy Read formats for consumers and businesses.

askVERA launches in two versions targeting individuals and organisations

The consumer (B2C) version allows individuals to upload or paste documents such as tenancy agreements, insurance policies or official letters to receive an instant simplified version. The business (B2B) version integrates into an organisation's existing workflows, enabling companies to simplify customer-facing content at scale and reduce queries caused by unclear communication.

Cornwall Council already piloted the technology before wider rollout

Ahead of the public launch, askVERA had already been deployed with organisations including Cornwall Council to make official documents more accessible.

Blue Shield Commits $300,000 to Alameda Food Bank's Medicine Program

Image
Blue Shield Commits $300,000 to Alameda Food Bank's Medicine Program

Oakland – – September 28, 2026 -- Blue Shield of California has pledged a $300,000 multi-year investment to Alameda County Community Food Bank (ACCFB), marking the first deployment under the nonprofit insurer's new statewide Food as Health initiative.

Blue Shield becomes the first and largest corporate sponsor of ACCFB's Food as Medicine program

The funding will expand a program that delivers medically supportive food and nutrition education to eligible Medi-Cal members managing chronic conditions. The investment strengthens infrastructure, data collection, and evaluation systems needed to scale the model beyond its current reach.

jaam automation Launches M. Platform to Bridge AI Adoption Gap

Image
jaam automation Launches M. Platform to Bridge AI Adoption Gap

London – September 28, 2026 -- jaam automation has launched M. by jaam, an Agentic Work Management platform designed to close the gap between AI adoption and measurable business impact. The launch responds to McKinsey data showing 88% of organisations now use AI, yet only 7% have fully scaled it across operations.

Adoption outpaces execution, McKinsey data shows

McKinsey research cited by jaam found that while 80% of employees report AI has improved their individual productivity, only 37% of organisations see a positive impact on EBIT. jaam positions M. as a fix for this disconnect, arguing that fragmented processes across people, applications and systems prevent AI agents from understanding what needs to happen next in a workflow.

AZP Grants Platinum Certification to Gateless AI Underwriting Tool

Phoenix – September 28, 2026 -- AZP Insurance Specialists has awarded Platinum certification to Gateless' Smart Underwrite®, marking the first technology provider to clear AZP's new AI Mortgage Technology Certification framework at its highest of four tiers.

Gateless earns top rating after 230,000 loans processed with zero claims

The Platinum designation reflects the performance of more than 230,000 loans manufactured and sold by lenders using Smart Underwrite®, all without a single claim filed. AZP said the certification evaluated the platform's governance, controls, auditability and operational maturity before granting the top rating.

Aristocrat Gaming Wins Triple Honors at Global Gaming Awards Americas

Image
Aristocrat Gaming Wins Triple Honors at Global Gaming Awards Americas

Las Vegas – September 28, 2026 -- Aristocrat Gaming secured three top honors at the Global Gaming Awards Americas, including Class 2 and Class 3 Land-Based Supplier of the Year and Slot of the Year for MONOPOLY Big Board Bucks.

Aristocrat extends eight-year winning streak in land-based supplier category

The company has now claimed the Class 3 Land-Based Supplier of the Year title for eight consecutive years and Slot of the Year for the same eighth-year streak. The Class 2 award marks the second straight year Aristocrat has topped that category.

CEO cites product performance as driver of repeat recognition

Craig Toner, CEO of Aristocrat Gaming, said the recognition reflects the company's focus on developing products and experiences that drive measurable performance outcomes for casino operators.

Honest Lasers Launches Triple-Wavelength Swiss Diode Laser Globally

Image
Honest Lasers Launches Triple-Wavelength Swiss Diode Laser Globally

Roggwil, Switzerland – September 28, 2026 -- Honest Lasers has launched the Honest Pro, a Swiss-manufactured diode laser system combining three wavelengths and integrated contact cooling for aesthetic and medical clinics worldwide.

Three wavelengths operate within a single clinical platform

The Honest Pro integrates 755 nm, 808 nm, and 1064 nm wavelengths in one system, each targeting melanin at different tissue depths to allow practitioners to treat varied hair and skin types without switching devices. The system runs at a maximum pulse rate of 10 Hz, which Honest Lasers designed for stable fluence delivery across repeated treatments during a full clinic workday.

Rocket Mortgage First Lender to Default to VantageScore 4.0

Image
Rocket Mortgage First Lender to Default to VantageScore 4.0

Detroit – September 28, 2026 -- Rocket Mortgage will become the first mortgage lender to adopt VantageScore 4.0 as its preferred credit scoring model for eligible loans, starting in the fourth quarter of 2026.

Rocket Mortgage found VantageScore 4.0 qualifies more clients while cutting scoring costs

Following roughly four months of testing, the lender determined VantageScore 4.0 helped more clients move forward in the mortgage process and reduced credit scoring costs. So far in 2026, Rocket Mortgage pulled 1.4 million credit reports using both VantageScore and FICO models to compare outcomes.

Clients who saved with the new model averaged $1,600 at closing

The lender's internal study found VantageScore 4.0 opens access for some clients who would otherwise go unserved and allows many to secure mortgages on better pricing terms. For those who benefited, average savings totaled $1,600 at closing.

Ethylene Oxide Market to Hit $94.28B by 2034 on PET, Sterilization Demand

Image
Ethylene Oxide Market to Hit $94.28B by 2034 on PET, Sterilization Demand

Pune – September 28, 2026 -- The global ethylene oxide market reached USD 62.95 billion in 2025 and is forecast to grow at a 4.59% CAGR through 2034, hitting USD 94.28 billion, according to a new report from Maximize Market Research.

Asia-Pacific dominates production and consumption, led by China, India, Japan and South Korea

The region's scale in petrochemical manufacturing, PET resin output and polyester fiber production has made it the largest ethylene oxide market as of 2025. Continued capital deployment into petrochemical facilities, healthcare infrastructure and industrial manufacturing is expected to sustain the region's lead through the forecast period.

Glycolic Acid Market to Hit $1.27 Trillion by 2034, Report Finds

Image
Glycolic Acid Market to Hit $1.27 Trillion by 2034, Report Finds

Pune, India – September 28, 2026 -- The global glycolic acid market is projected to grow from USD 723.75 billion in 2025 to USD 1,267.06 billion by 2034, expanding at a compound annual growth rate of 6.42%, according to a new report from Maximize Market Research.

North America dominates demand as dermatology and pharmaceutical use expand

North America leads the global market, driven by strong uptake of glycolic acid in skincare, cosmetics, dermatology, and pharmaceutical formulations. The U.S. remains the largest consumer market as chemical peels, anti-aging creams, exfoliating serums, and acne treatments built on alpha hydroxy acid (AHA) chemistry gain wider adoption. The U.S. FDA identifies glycolic acid as one of the most common AHAs used in cosmetic products for exfoliation and pH adjustment.

Widehall's American Growth Summit Draws Cabinet, Congress, CEOs to DC

Image
Widehall's American Growth Summit Draws Cabinet, Congress, CEOs to DC

Washington – September 28, 2026 -- Widehall will convene its second annual American Growth Summit on Tuesday, September 29, 2026, gathering senior White House officials, members of Congress, and chief executives from Citi, NVIDIA, Siemens, and Coinbase at the Willard InterContinental in Washington, D.C. to address policy shaping America's economic trajectory.

BRC Group to Acquire Sangoma Technologies in $204 Million Deal

Los Angeles and Toronto – September 28, 2026 -- BRC Group Holdings, Inc. (NASDAQ: RILY) has agreed to acquire Sangoma Technologies Corporation (TSX: STC; NASDAQ: SANG) in a deal valuing the communications provider at an enterprise value of approximately $204 million, or C$289 million.

Combined communications revenue reaches $441 million on a trailing-twelve-month basis

BRC's existing communications businesses and Sangoma generated a combined $441 million in trailing-twelve-month revenue as of June 2026, with $241 million from BRC's units and $200 million from Sangoma. BRC's communications portfolio alone produced approximately $52 million in segment income over the same period.